Skip Navigation LinksHome > Published Ahead-of-Print > Bone Scintigraphy in Osteosarcoma: A Single Institution Exp...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000182
Clinical and Laboratory Observations: PDF Only

Bone Scintigraphy in Osteosarcoma: A Single Institution Experience.

Powers, Jacquelyn M. MD; Cost, Carrye MD; Cederberg, Kevin MD; Leonard, David PhD; Leavey, Patrick J. MD, MB, BCh, BAO, LRCP&SI, MRCPI, DCH

Published Ahead-of-Print
Collapse Box

Abstract

Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.

(C) 2014 by Lippincott Williams & Wilkins.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.